Monthly Archives: July 2017

Bipolar Disorder Market – Global Industry Analysis and Forecast 2017 – 2025

Bipolar disorder, commonly known as manic depression, is a type of mental illness which is characterized by mood swings. Mood episodes are of two types: manic and depressive episodes. The changes in the mental state bring out sudden high or low moods in a person. An individual suffering from bipolar disorder can be happy, joyful, and energized at a particular moment and can also be sad, hopeless, and sluggish at the next moment. This mental illness is termed as bipolar disorder due to these different moods or two poles of mood. Through many research activities, it is observed that certain genes are responsible for the development of bipolar disorder. Individuals with a family history of bipolar disorder are most likely to develop the illness. These kind of mood episodes can hamper the image of an individual at a school or at a job or even in the society.

Obtain Report Details @
http://www.transparencymarketresearch.com/bipolar-disorder-treatment-market.html

Increase in awareness about diagnosis and treatment of bipolar disorder and unmet needs in the treatment of the disorder are the major drivers for the growth of the market. Increasing acceptance of society regarding mental illness is encouraging individuals to get treated. In addition, growth in technological advancement in identifying genetic disorders and increase in treatment options for genetic disorders are major drivers of the market growth. Government initiatives such as launch of Bipolar Disorder Phenome Database, funded by the National Institute of Mental Health (NIMH), provide complete information regarding signs and symptoms of the illness. This factor has further contributed to the growth of the market. However, factors such as stringent regulatory frameworks, side effects of anticonvulsants, and limited number of approved anticonvulsants hamper the growth of the market.

The global bipolar disorder market is segmented based on types of bipolar disorder, drug class, mechanism of action, and geography. Based on types of bipolar disorder, the market is classified into bipolar I disorder, which is mania or mixed episode; bipolar II disorder, which is hypomania and depression; and cyclothymia, which is hypomania and mild depression. According to drug class, the market is segmented into mood stabilizers, anticonvulsants, antipsychotics, antidepressants, and anti-anxiety drugs. In terms of mechanism of action, the market is segmented into selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines, beta blockers, and others.

Geographically, the global bipolar market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global bipolar disorder market due to increased awareness and larger availability of treatment options. In the region, the U.S. has a significant market share in terms of revenue, followed by Canada. Europe is the second leading region, contributing to the growth of the market in terms of revenue, with the U.K. and Germany having major share of the market. Asia Pacific is a highly potential market with emerging countries such as India and China. The market in the region is expected to expand at a high CAGR during the forecast period. Increase in awareness about the disease in countries such as India is likely to boost the growth of the market. Latin America and Middle East & Africa are expected to contribute highly to the growth of the market due to improving economy and rising awareness about the mental illness.

Key players operating in the global bipolar disorder market include Abbott Laboratories, Bristol-Myers Squibb, AstraZeneca plc, Eli Lilly and Company, GlaxoSmithKline plc, Merck & Co., Inc., Johnson & Johnson, Pfizer Inc., Cephalon Inc., Gedeon Richter plc, H. Lundbeck A/S, Otsuka America Pharmaceutical Inc., Repligen Corporation, and Validus Pharmaceuticals LLC.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20855

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Colposcope Market Global Industry Volume By Region 2017 – 2025

Colposcope is a type of microscope which has lens with light source to observe and examine the uterine cervix. The colposcope is employed to observe and identify abnormal tissue or blood vessel development in the vagina and around the cervix. Furthermore, it helps obtain tissue samples for biopsy intended to diagnose cancer. Colposcope presents a large and detailed view of the various parts of the uterus, helping doctors and healthcare professionals to visually differentiate between a normal and abnormal noticeable tissue. Subsequently, if necessary, they can forward it to the laboratory for further pathological evaluation and investigation by taking directed biopsies. The important application of colposcopy is to avoid cervical cancer by detecting pre-cancerous tumor cells early and treating cancer in the early stage. Colposcope, which is fitted with a specialized camera, is also utilized in identifying and collecting evidence for a victim of sexual assault and rape. Additionally, it is employed to examine various problems related to the uterus. A colposcope is used to examine visible abnormal tissue. Its working mechanism is similar to that of a monocular microscope or lighted binocular. Its function is to present an enlarged and magnified view of the vagina, cervix, and vulvar surface. Coloscopy also has certain drawbacks and complications, which may include bleeding, failure to identify the lesion, and infection at the biopsy site or endometrium.

Obtain Report Details @
http://www.transparencymarketresearch.com/colposcope-market.html

A number of factors affect the growth of the colposcope market. Key factors affecting the expansion of the colposcope market include rising demand for colposcope for diagnosis, development and advancement in colposcope devices, increasing number of the cervical cancer patients, and rise in global geriatric population. Other key drivers are technological advancement in diagnostic devices, increase in the number of diagnosis procedures, and rise in the number of uterus problems related to the elderly population. The market is also witnessing restraints or challenges such as development of other diagnostic procedures and technologies and stiff competition among existing colposcope device manufacturers. Moreover, product recalls, government regulations for reduction of overall health care cost, and subsequent upswing in bulk purchasing through INHs and GPOs (Group Purchasing Organizations) are restraining the market.

The colposcope market can be segmented into product type, end-user, and region. In terms of product type, the market can be segmented into optical colposcope, video colposcope, accessories, and consumables. The accessories segment can be further segmented into camera, display, and others. The video colposcope segment holds significant share of the market. In terms of end-user, the market can be segmented into hospitals, gynecology clinics, diagnostic centers, and research & academics. The hospitals segment dominates the colposcope market.

In terms of geography, the colposcope market can be segmented into five major regions: North America (U.S. and Canada), Europe (Germany, France, U.K., etc.), Asia Pacific (Australia, New Zealand, China, Japan, India, etc.), Latin America (Brazil, Mexico, etc.), and Middle East & Africa (GCC Countries, Saudi Arabia, South Africa, etc.). North America holds prominent share of the market due to advanced technology in the region. The emerging markets in Asia Pacific, Latin America, and Middle East & Africa are estimated to expand considerably during the forecast period from 2017 to 2025. This is attributed to increasing prevalence of the cervical cancer, increasing investments by key players operating in these countries, expanding health care industry, and the aging population leading to increase in the patient population in these countries. India, China, and Brazil are expected to fuel expansion of the market due to increasing investments by government bodies to enhance health care facilities.

Key companies operating in the global colposcope market are CooperSurgical, Inc., Edan Instruments, Inc., MedGyn Products, Inc., Wallach Surgical Devices, Kernel Medical Equipment Co., Ltd, Seiler Instrument Inc., Gynex Corporation, and ZEISS Group

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22901

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Breast Implant Market By Analysis of Major Industry Segments 2017 – 2025

Breast implants are medical devices that are used to augment the size of breasts, either for cosmetic applications or reconstruction purpose, following mastectomy or to correct a congenital abnormality. Breast augmentation, commonly known as breast enlargement, is a popular surgical procedure that improves the size and shape of the breast. The procedure involves the use of breast implants and fat, called as fat transfer breast augmentation, in order to enhance and improve the size of the breasts. In clinical terms, breast augmentation is referred as augmentation mammoplasty. According to a statistics by American Society of Plastic Surgeons (ASPS), the average cost of a breast augmentation surgery was US$ 3,708 in 2014. Socioeconomic status is a primary factor creating a high demand for breast implants globally. The primary customer base for breast augmentation are women belonging to middle- and high-income families. The World Bank estimates that the global annual disposable income per capita for women is expected to increase at a CAGR of approximately 6% in the next few years, driving the expansion of the aesthetic market globally. Additionally, significant rise of the world’s middle-class population over the last few years, resulting in increase in purchasing power and discretionary spending, is indicative of the stability and growth of the global breast implant market. It has been estimated that much of this growth in purchasing power is likely to come from emerging markets, which is attributed to rising disposable income.

Obtain Report Details @
http://www.transparencymarketresearch.com/breast-implant-market.html

Rise in global disposable income and growth in reimbursement rates for reconstructive procedures are expected to propel the market growth for breast implant during the forecast period. In addition, availability of premium-priced products, expansion of product portfolio, and increase in prevalence of breast cancer are factors driving the global market growth for breast implant. As per data released by the World Health Organization (WHO), in 2012, 1.7 million women were diagnosed with breast cancer, leading to approximately 522,000 deaths during the same year. Hence, increase in breast cancer prevalence is a major factor contributing to revenue growth of the breast implant market across the globe. However, risk of developing serious complications and lack of skilled nursing facilities in developing regions may hamper the market share. Large amount of documented evidences supporting the possibility of developing breast cancer after getting breast implants is one of the prime reasons hampering the growth of the market. In 2011, FDA indicated possible association between breast implants (saline and silicone) and anaplastic large-cell lymphoma (ALCL). Anaplastic large-cell lymphoma is a rare type of non-Hodgkin’s lymphoma (NHL), characterized by abnormal growth of T-lymphocytes. According to the National Cancer Institute, the disease affects 1 in 500,000 women globally. However, in the U.S., ALCL affects 3 in 100 million women who have undergone breast implants surgery.

The global breast implant market is segmented on the basis of implant type, application, end-user, and region. Based on implant type, the market is categorized into saline breast implants and silicone breast implants. The silicone breast implants segment is expected to account for a significant share of the market in the near future. The large share of the segment are attributed to comparatively less adverse reactions associated with it, availability of expanded product line, and premium-priced products. On the basis of application, the market is divided into cosmetic surgery and reconstructive surgery. Breast augmentation remains one of the top cosmetic surgical procedures globally; hence, the cosmetic surgery segment held a major share of the market in 2016 and the trend is expected to continue in the near future. Rise in emphasis on physical appearance and studies reporting increased self-esteem and confidence in women with cosmetic breast augmentation are expected to drive the growth of the market for breast implant in cosmetic applications. Further, adoption of reconstructive surgery is expected to increase significantly in women undergoing mastectomy.

On the basis of end-user, the market is segmented into hospitals, dermatology clinics & cosmetic centers, and ambulatory surgical centers. The hospitals segment is expected to be the most attractive end-user segment of the market during the forecast period owing to the rising popularity of surgical procedures that are performed in hospitals rather than cosmetology clinics. According to the International Society of Aesthetic Plastic Surgery, majority of surgical procedures are performed in hospitals accounting for approximately 66.5% share of the global market.

Based on geography, the market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global breast implant market during the forecast period owing to rise in awareness and adoption of various silicone breast implant services, growth in health care infrastructure, and increase in incidence of breast cancer.

Key players operating in the market include Allergan, Plc, Mentor Worldwide LLC, GC Aesthetics plc, Sientra, Inc., Groupe Sebbin SAS, POLYTECH Health & Aesthetics GmbH, Establishment Labs S.A., CEREPLAS, and HansBiomed Co. Ltd.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22895

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Biliary Stents Market By Analysis of Major Industry Segments 2017 – 2025

Stent is referred as plastic or metal tube inserted in human body into lumen or duct to keep the passage open. Various types of stents such as expandable stents and simple plastic stents are used for various purposes. Different types of stents such as coronary, vascular, and biliary stents are employed for various purposes. ‘Biliary’ is referred to the bile duct, which is a long tube-like structure carrying bile fluid. Bile plays an important role in food digestion. It is secreted by liver into intestinal passage through the bile duct, which opens in intestine. Stents applied in biliary disorders are called biliary stents. Biliary stents very first introduced in 1979 palliation of malignant biliary strictures which offered paradigm shift in biliary disorder. Biliary stents are used in various applications such as malignant biliary obstruction, biliary strictures, and leaking of bile duct. Akin to any other devices, biliary stents are associated with a few complications; of this, occlusion of the stent is the most common reason for stent failure. However, biliary stents have become an integral part in palliation of malignant strictures. Plastic and metal biliary stents are available in the market. Plastic biliary stents are composed of polyethylene and Teflon. These are available in a variety of configuration. Companies have modified stents to decrease the biofilm formation, thereby increasing patency time which includes coating with specialized material and windsock distal design. Plastic stents are generally radiopaque and available with introducer kits. The self-expanding metal stents (SEMs) offers the advantages due to increased diameter of stent thereby reducing recurrent obstruction and increasing patency duration. Some self-expanding metal stents have retrieval loops such as wall flex that facilitate its repositioning and removal after the initial placement. Covered self-expanding metal stents are now evaluated for application in benign disease. Plastic biliary stents are used separately or with an associated pusher or introducer catheter.

Obtain Report Details @
http://www.transparencymarketresearch.com/biliary-stents-market.html

Increase in patency duration of plastic and self-expanding metal stents remains an integral area of future research. High prevalence of biliary diseases across the globe is driving the biliary stents market. Rise in surgical procedures of biliary diseases is expected to boost the biliary stents market across the globe. Increase in usage of substitutes in biliary surgeries is anticipated to restrain the biliary stents market. High cost of procedure of biliary stents insertion is also adversely affecting the market growth. Further investigation on how to increase patency period for plastic and metal stents could be the research highlight in near future. Biodegradable stents that do not require removal are being developed. Advanced research studies need to be conducted in this field.

The global biliary stents market can be segmented based on type, application, and geography. In terms of type, the biliary stents market can be divided into plastic, metal, and others. The plastic segment is estimated to expand in the near future due to the comparatively low cost, and easy insertion and removal during surgeries. Self-expanding metal stents could be the second sub-segment of biliary stent type due to high price factor. In terms of application, the biliary stents market can be divided into malignant obstruction, benign biliary strictures, biliary leaks, and others. Malignant obstruction and benign biliary strictures segments are likely to expand at a rapid pace during the forecast period due to their rising prevalence and lack of substitutes to biliary stent insertion.

Based on geography, the global biliary stents market can be segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is expected to account for major share of the global biliary stents market during the forecast period owing to the developed healthcare infrastructure and rise in population suffering from biliary disorders. Europe is anticipated to be the second largest region of the global biliary stents market. India and China are the developing countries in Asia Pacific. Major players operating in the global biliary stents market include GE Healthcare, Medtronic plc, Stryker Corporation, Blue Belt Technologies Inc., Cook Group Incorporated, Brainlab AG, Boston Scientific Corporation, and Abbot Vascular among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22892

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Anesthesia Vaporizers Market – Global Industry Volume and Region Analysis – 2025

Anesthesia is a medical term that means insensitivity to pain. Anesthesia is widely used during surgical procedures to bring unconsciousness to patients. Anesthesia vaporizers are devices that convert liquid inhalation agents into vapors. This vapor and oxygen are collectively delivered to the patient via inhalation route, primarily during pre-surgical procedures. An anesthesia delivery system typically consists of a machine that contains a breathing circuit. The necessity of these devices depends on the type of surgery performed. The concentration of dose differs in every case.

Obtain Report Details @
http://www.transparencymarketresearch.com/anesthesia-vaporizers-market.html

With advancements in surgical procedures and technological improvements, the average life expectancy of individuals has increased significantly. Rise in the geriatric population worldwide is amongst the important drivers of the global anesthesia vaporizers market. The reasons behind them are, the geriatric population is highly prone to the degenerative diseases, infections and chronic illnesses which ultimately results in an increased in incidences of surgeries and therapeutics, as ageing peoples lacks immunity to fight against them. This requires continuous monitoring, which propels the global anesthesia vaporizers market. Newly developed anesthesia vaporizer devices come with an advanced decision-support system (DSS), which also supports the monitoring capabilities; for instance, end-tidal concentrations of carbon dioxide and oxygen, inhalation anesthetics, and transcutaneous oxygen saturation. These advancements provide data analysis to clinicians and surgeons, which can help them take decisions during surgical procedures or other therapeutic treatments. Consequently, a few of the side-effects involved such as cognitive disturbances and post-operative delirium related to anesthesia, primarily in elderly patients, act as restraints for the market. Rise in the cost of surgical procedures and instruments and poor reimbursement policies are also important factors likely to hamper the global anesthesia vaporizers market during the forecast period.

The global anesthesia vaporizers market can be segmented on the basis of product, agent specificity, and end-user. Based on product, it can be segmented into plenum vaporizers and drawover vaporizers. Based on agent specificity, the anesthesia vaporizers market can be segmented into agent-specific and multiple agents. Based on end-user, the market can be segmented into hospitals, ambulatory surgical centers, clinics, and nursing homes. Rise in the number of hospitals, clinics, ambulatory surgical centers, and nursing homes and the availability of advanced infrastructure are a few factors responsible for growth of the anesthesia vaporizers market. Additionally, presence of skilled personnel in hospitals has significantly fueled the anesthesia vaporizers market.

Geographically, the global anesthesia vaporizers market has been segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. North America is a major market for anesthesia vaporizers, due to the rising number of surgeries in the region led by elevated awareness amongst surgeons about the benefits of anesthesia devices. Additionally, with widespread technological advancements and increasing competition in the market, demand for superior technological advancements for better results has been increasing. The market in Asia Pacific is anticipated to witness high growth during the forecast period, increased awareness about health care, unmet needs of the large population, rapidly developing health care network, rise in the disposable income, and favorable reimbursement policies in the region. These factors have also made the practice of advanced techniques in anesthesia monitoring easier in the region.

Major players operating in the global anesthesia vaporizers market are Drägerwerk, GE Healthcare, Penlon, Meditec International England, Oricare, Spacelabs Healthcare, Beijing Siriusmed Medical Device, Baxter International, Inc., Intersurgical Limited, Medtronic, Inc., Mindray Medical International Limited, Nihon Kohden Corporation, Philips Healthcare, and Smiths Medical, Inc. New collaborative developments and new product techniques are some of the strategic initiatives taken by the companies to remain in the competition.

Major players operating in the market are Biogen Idec, Inc., Bristol-Myers Squibb, Celgene Corporation, ERYTECH Pharma, F. Hoffmann-La Roche Ltd., Genzyme Corporation, GlaxoSmithKline Pharmaceuticals Limited, and Pfizer, Inc.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22889

About Us  

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Lexiscan Nuclear Stress Test Market Analysis, Trends and Forecast by 2017 – 2027

Lexiscan or regadenoson is a stress agent, which typically works by increasing blood flow in the arteries of the heart. Lexiscan is specifically used for radionuclide myocardial perfusion imaging (MPI) in patients who are unable to bear adequate exercise stress. In this test, typically, patients are asked to walk on a treadmill or ride a stationary bicycle. The aim is to increase patient’s heart rate until it is adequately stressed.

The heart is a specified muscle and like other muscles in the body it needs oxygen and nutrients so that it can continuously pump blood throughout the body. Regadenoson is injected intravenously in preparation with a radiologic (X-ray) examination of blood flow through the myocardial perfusion imaging (MPI) nuclear stress test or coronary artery test.

Obtain Report Details @
http://www.transparencymarketresearch.com/lexiscan-nuclear-stress-test-market.html

On April 10, 2008, Lexiscan was approved by the U.S. Food and Drug Administration (FDA). It is marketed by Astellas Pharma. It is approved in the EU under the name Rapiscan. Currently, it is being marketed by GE Healthcare, which is being sold mainly in the United Kingdom (U.K.) and Germany.

MPI test is taking pictures of the blood flow in a patient’s heart. This test provides detailed anatomical images which can be used to diagnose and evaluate conditions in coronary artery disease. Coronary artery disease progresses when arteries become damaged or diseased. Usually, coronary arteries are damaged when they are accumulated with deposits called plaques. Shortness of breath is a usual indication of coronary artery disease. MPI test images can tell a doctor if a patient’s heart is bloated and can measure its overall functioning, for example ejection fraction.

The choice of lexiscan nuclear stress test modality depends on many factors. Some of the important factors are resting electrocardiogram (ECG), ability to perform exercise, and clinical signals performing the test.

The global lexiscan nuclear stress test market is driven by rise in incidence of coronary heart diseases. According to a recent analysis in the medical journal The Lancet, the number of people with peripheral arterial disease (PAD) has increased by 24% in the past ten years. Globally, millions of people are suffering with heart rhythm disorder atrial fibrillation also called AFib. Currently, nearly 2.7 million people in the U.S. have AFib. This number is expected to increase significantly due to rise in geriatric population. The formation/accumulation of plaque in the arteries in the limbs is one of the major reasons that can cause heart attack or stroke. Other causes of rise in heart diseases are smoking, obesity, and changes in lifestyle. On the other hand, side effects and safety issues related to lexiscan nuclear stress test are projected to restrain the global lexiscan nuclear stress test market. People may experience side effects depending on individual conditions. The most common side effects that followed application of lexiscan test were headache, flushing, chest pain, nausea, feeling hot, dizziness, and nausea. Other factors likely to hamper market growth are rise in cost of overall treatment and surgeries.

Key players operating in the lexiscan nuclear stress test market are Astellas Pharma, Inc. and GE Healthcare. Moreover, small number of players operate in this market at the regional level, especially in low to medium income parts of the world.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22805

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

Global Outlook for Cough Assist Devices Market By Key Trends and Analysis 2027

Cough assist device helps to clear the lung secretions by helping the patient with his breathing. When a person is assisted with a cough assist device, the machine creates a positive pressure when the patient takes in air and while expiring the suction created expires the air outside. This difference in pressure makes coughing more stronger and effecting, helping to bring out the congestion.

The cough assist device is important for respiratory care and in cases of critical illness. This device is a proactive requirement for spinal muscular atrophy patient regardless of the type. The device helps secretion of cough out of the lungs by creating a quick reverse in the flow directions. The stimulation of the cough dramatically improves the airway clearance thereby helping the lungs to develop and grow.

Obtain Report Details @
http://www.transparencymarketresearch.com/cough-assist-devices-market.html

Cough Assist Devices Market: Drivers and Restraints

The major driver of the cough assist device market is the increasing prevalence of respiratory problems. Moreover, the changing lifestyle such as smoking and the high air pollution has all contributed towards the use of this portable cough assist device. The person does not have to spend hospital bed cost and medication every time he suffers from some airway disorder. With cough assist device, the patient can have a quick access to the device.

According to the Reinsurance Group of America out of the four million people who die from chronic respiratory diseases each year, 90% deaths are from low and middle-income countries. While developing countries include problems such as respiratory system infections and tuberculosis, developed countries include high level of chronic obstructive pulmonary disease, asthma, and lung cancer. This factor is expected to propel the demand for assist cough devices.

Cough Assist Devices Market: Segmentation

Cough assist devices market is classified on the basis of product, choice of air delivery part and region.

Based on application the cough assist devices market is segmented into the following:

  • Automatic cough assist device
  • Manual cough assist device

Based on choice of air delivery part the cough assist devices market is segmented into the following:

  • Face mask
  • Mouth piece
  • Adaptar

Cough Assist Devices Market: Overview

Environmental pollution causes seriously respiratory diseases such as COPD and asthma and globally the number is still increasing. This is expected to propel the demand for sudden asthmatic attack health devices globally. There are a number of organizations who are coming forward to contribute towards the helping the people suffering from chronic conditions. The soaring insurance coverage and hospital costs have increased patients treated in the non-hospital settings. The respiratory disorders are a key therapeutic area and hence there is an increase in the number of patients being treated for asthma and sleep apnea in the homecare setting.

Cough Assist Devices Market: Region-wise Outlook

In terms of geography, the cough assist devices market has been divided into five regions including North- America, Asia- Pacific and Middle-East & Africa, Latin America and Europe. North America region dominated the cough assist devices with the presence of major companies and the funds received towards home healthcare devices. Asia Pacific is the fastest growing region as there is an increasing interest of venture capitalist towards the home healthcare services. Medwell Ventures received US$21 million to expand the services in Tier I and Tier II towns along with increasing manpower.

Cough Assist Devices Market: Key Market Participants

Some of the market contributors to the cough assist devices market are Koninklijke Philips N.V., Hill-Rom, Percussionaire Corporation, Dima Italia Srl, Emerson, United Hayek Industries Inc., and Ventec Life Systems.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22766

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/